Value of electroacupuncture combined with non-steroidal drugs in adjuvant treatment of breast cancer

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2019
INTERVENTION: Group 1:electroacupuncture combined with non‐steroidal drug;Group 2:simple non‐steroidal drugs; CONDITION: breast cancer PRIMARY OUTCOME: Basic life activity ability (BADL) score 24 hours after surgery; INCLUSION CRITERIA: 1. Patients undergoing breast cancer surgery; 2. Aged 18‐75 years old; 3. BMI index 18‐30kg/m2; 4. ASA grade I to III; 5. Voluntary signing of informed consent.
Epistemonikos ID: f9dcd616b4d7b99a2d024f591db5d0da60cc5d3d
First added on: Aug 24, 2024